RRC
69
4
IRM
65
6
DAL
51
7
PEG
57
2
IBM
57
3
USB
66
12
HBI
52
6
MKC
60
4
WY
24
4
GT
49
3
WBA
37
5
LEG
55
-2
ADBE
55
4
APD
49
4
LMT
54
-6
BLK
61
4
AAL
27
7
TSCO
48
2
MMC
62
2
KLAC
65
4
RRC
69
4
IRM
65
6
DAL
51
7
PEG
57
2
IBM
57
3
USB
66
12
HBI
52
6
MKC
60
4
WY
24
4
GT
49
3
WBA
37
5
LEG
55
-2
ADBE
55
4
APD
49
4
LMT
54
-6
BLK
61
4
AAL
27
7
TSCO
48
2
MMC
62
2
KLAC
65
4
Financhill
Back

OptimizeRx 10K Form

Buy
52

OPRX
OptimizeRx

Last Price:
$10.06
Seasonality Move:
8.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-05 10Q OPRX/OptimizeRx Quarterly
2020-05-06 10Q OPRX/OptimizeRx Quarterly
2020-03-26 10K OPRX/OptimizeRx Annual
2019-11-05 10Q OPRX/OptimizeRx Quarterly
2019-08-07 10Q OPRX/OptimizeRx Quarterly
2019-05-08 10Q OPRX/OptimizeRx Quarterly

Receive OPRX News And Ratings

See the #1 stock for the next 7 days that we like better than OPRX

OPRX Financial Statistics

Sales & Book Value

Annual Sales: $92.1M
Cash Flow: $78K
Price / Cash Flow: 41.42
Annual Sales: $6.34
Price / Book: 1.59

Profitability

EPS (TTM): -1.10000
Net Income (TTM): $-20.1M
Gross Margin: $59.4M
Return on Equity: -16.71%
Return on Assets: -11.57%

OptimizeRx Earnings Forecast

Key OptimizeRx Financial Ratios

  • The Gross Profit Margin over the past 18 years for OPRX is 64.45%.
  • The Selling, General & Administrative Expenses for OPRX have been equal to 66.50% of Gross Profit Margin.
  • The Research & Development expenses have been 2.49% of Revenue.
  • The Net Earning history of OPRX is -21.83% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 7 years.

OptimizeRx Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Technology
Sector: Health Care
Current Symbol: OPRX
CUSIP: 68401U
Website: optimizerx.com

Debt

Debt-to-Equity Ratio: 0.28
Current Ratio: 2.89
Quick Ratio: 2.77

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 17.13

OPRX Technical Analysis vs Fundamental Analysis

Buy
52
OptimizeRx (OPRX) is a Buy

Is OptimizeRx a Buy or a Sell?

  • OptimizeRx stock is rated a Buy
    The current OptimizeRx [OPRX] share price is $10.05. The Score for OPRX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.